Biocartis Group NV

ENXTBR:BCART Stock Report

Market Cap: €27.2m

Biocartis Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Roger Moody

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.7yrs
CEO ownershipn/a
Management average tenure2yrs
Board average tenure6.9yrs

Recent management updates

Recent updates

Investors Give Biocartis Group NV (EBR:BCART) Shares A 31% Hiding

Jun 17
Investors Give Biocartis Group NV (EBR:BCART) Shares A 31% Hiding

Analysts Have Been Trimming Their Biocartis Group NV (EBR:BCART) Price Target After Its Latest Report

Feb 27
Analysts Have Been Trimming Their Biocartis Group NV (EBR:BCART) Price Target After Its Latest Report

We Think Biocartis Group (EBR:BCART) Has A Fair Chunk Of Debt

Mar 03
We Think Biocartis Group (EBR:BCART) Has A Fair Chunk Of Debt

What Kind Of Shareholders Own Biocartis Group NV (EBR:BCART)?

Jan 27
What Kind Of Shareholders Own Biocartis Group NV (EBR:BCART)?

What We Learned About Biocartis Group's (EBR:BCART) CEO Compensation

Dec 06
What We Learned About Biocartis Group's (EBR:BCART) CEO Compensation

What Can We Learn About Biocartis Group's (EBR:BCART) CEO Compensation?

Sep 01
What Can We Learn About Biocartis Group's (EBR:BCART) CEO Compensation?

What Type Of Returns Would Biocartis Group's(EBR:BCART) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Jul 28
What Type Of Returns Would Biocartis Group's(EBR:BCART) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

CEO

Roger Moody

1.7yrs

Tenure

Mr. Roger Moody is Chief Executive Officer of Biocartis Group NV from April 24, 2023. Mr. Moody has experience in the technology and healthcare industry and brings a unique combination of deep knowledge of...

Leadership Team

NamePositionTenureCompensationOwnership
Roger Moody
Chief Executive Officer1.7yrsno datano data
Randy Polonsky
Chief Financial Officerless than a yearno datano data
Benoit Devogelaere
Chief Technology Officer7yrsno datano data
W. Korn
Chief Medical & Scientific Officerless than a yearno datano data
Renate Degrave
Head of IR & Corporate Communicationsno datano datano data
Susy Spruyt
Head of People & Organization9.9yrsno datano data
Erwin Sablon
Head of R&D and Alliance Management12.3yrsno datano data
Reginald Van Genechten
Head of Manufacturing & Supply Chain8.8yrsno datano data
Sarah Baudenelle
Head of Operations & On-Market Product Support1.3yrsno datano data
David Dejans
Chief Commercial Officer2.3yrsno datano data
Gina Wallar
Chief Business Officerless than a yearno datano data

2.0yrs

Average Tenure

56yo

Average Age

Experienced Management: BCART's management team is not considered experienced ( 2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Christian Reinaudo
Independent Director6.6yrs€84.00kno data
Herman Verrelst
Independent Chairman of the Board7.3yrs€436.78kno data
Jean-Louis Vincent
Member of Scientific Advisory Boardno datano datano data
Ann-Christine Sundell
Non Executive Independent Director6.9yrs€47.50kno data
Pasi Antero Janne
Member of Scientific Advisory Boardno datano datano data
Geert Maertens
Chairman of Scientific Advisory Boardno datano datano data
Alberto Bardelli
Member of Scientific Advisory Boardno datano datano data
Eric Cutsem
Member of Scientific Advisory Boardno datano datano data
Josep Tabernero Caturla
Member of Scientific Advisory Boardno datano datano data
Bert Niesters
Member of Scientific Advisory Boardno datano datano data
Luc Gijsens
Non-Executive Independent Director6.9yrs€49.50kno data
Michael Press
Member of Scientific Advisory Boardno datano datano data

6.9yrs

Average Tenure

66yo

Average Age

Experienced Board: BCART's board of directors are considered experienced (6.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 10:48
End of Day Share Price 2024/12/20 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biocartis Group NV is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott BardoBerenberg
Hugo SolvetBryan Garnier & Co
Guy SipsKBC Securities NV